C. diff Summit Spotlights pharmacists’ Role in Infectious Disease Fight

⁢ Updated May 25, 2025

Washington, D.C.— The Peggy Lillis Foundation recently convened its 10th National C‌ diff ‍Summit, bringing together advocates, survivors, healthcare professionals, and policymakers to address the ongoing⁢ challenges of Clostridioides​ difficile (C. difficile) infection. The summit aimed to boost awareness and advance strategies‌ for C. difficile ⁣ prevention and⁤ treatment.

Christian John Lillis, co-founder and CEO of the Peggy Lillis Foundation, discussed key ‌takeaways⁣ from the⁣ 2025 summit. He emphasized⁤ the underrecognized importance of pharmacists in infectious disease care, the changing demographics of C.difficile ⁣advocates, and the⁤ persistent ⁢struggles ⁢faced by patients, despite therapeutic advancements. Lillis also highlighted broader societal and policy factors⁤ impacting public‍ health and the need for sustained advocacy and interdisciplinary collaboration to combat C. difficile.

Lillis noted the summit underscored the vital role of infectious disease pharmacists. Many attendees, particularly new volunteers, gained a deeper gratitude for their expertise. According to Lillis,one board member,an infectious disease doctor,relies heavily on an IV‍ pharmacist due to the rapid changes in the field. This collaboration ⁤is critical for optimal patient care.

The summit ‍also saw an influx of younger volunteers, including a young mother⁤ who brought her infant to lobbying meetings.lillis emphasized that these citizens have the right to advocate for their needs.

Despite progress in FDA-approved treatments, Lillis expressed concern that⁣ patient experiences with C.difficile ‍have not substantially improved. He suggested that the COVID-19‍ pandemic may have caused a setback. Lillis also voiced apprehension about a perceived shift in focus within the‌ Department of Health and Human Services toward chronic diseases, possibly overlooking the ongoing threat​ of ⁣infectious diseases.

Even the healthiest person can succumb to an infection. And to ‍say or else is to mislead the⁤ public.

Lillis stressed that infectious diseases can effect anyone,regardless of their health status. He also noted that attendees from various political backgrounds recognized the importance of public health agencies, even if reforms are needed.some ​participants acknowledged that these agencies may be understaffed to handle their responsibilities effectively.

Another issue raised at the summit was the sense of personal blame felt by many C. difficile patients. Lillis connected this to the‌ politicization of COVID-19, where individuals may feel responsible for​ contracting the virus. He argued that public health is a societal issue, and blaming individuals misses ⁤the point.

Public health is public health, and its really a⁢ societal​ issue, and to frame it as ⁤an individual’s mistake or an individual’s bad⁣ behavior led to this is to miss‌ the entire point of public health.

Drawing parallels to the HIV/AIDS crisis, Lillis emphasized that diseases are not a result of individual failings but require societal investment in public ⁣health. He argued that factors like food availability, sick leave policies,⁣ and access to care all influence a ⁢population’s health. He further asserted that⁤ many chronic diseases stem from policy choices made over decades, ⁣including agricultural policies, lack of sick time, and stagnant minimum ​wages.

What’s next

looking ahead, the ⁣Peggy Lillis Foundation ‌aims to continue advocating for‌ policies that support public health infrastructure and address the societal⁢ factors contributing to infectious diseases like C. difficile. The foundation will also focus on ⁣educating⁤ the public about the crucial role of pharmacists in infectious disease management and empowering‍ patients to advocate for better care.